Comment at FDA Public Meeting on Dietary Supplements
Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…
FDA Dietary Supplements Comment
TINA.org submitted a comment to the FDA regarding supplement marketers’ use of unsubstantiated disease-treatment claims and urging the agency to do more to protect susceptible populations, including the elderly.
How We Took Action
May 16, 2019: TINA.org’s Executive Director provides comment to the FDA at its public meeting on Responsible Innovation in Dietary Supplements.
Featured
Prevagen Is Going to the Dogs
Second Circuit rules FTC/NY case against Prevagen can proceed.
Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection
Pending class-action settlement leaves consumers behind.